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DISTINCT PHENOTYPIC CHANGES BY PACAP AND VIP IN 
LIPOPOLYSACCHARIDE-STIMULATED BV2 MICROGLIAL 
CELLS
Microglia are resident glial cells of the brain. These cells regulate brain development, maintain homeostasis of neuronal networks, and promote injury repair [1]. Due to their phagocytic
activity, microglia serve as brain macrophages, but are distinct from other tissue macrophages owing to their unique phenotype and tight regulation by the central nervous system (CNS)
microenvironment [2]. However, there is evidence suggesting that aberrantly activated microglial cells play a key role in the progressive neuronal loss seen in many neurodegenerative
diseases [3]. Pituitary adenylate cyclase-activating polypeptide (PACAP) and the homologue vasoactive intestinal peptide (VIP) are two neuropeptides, both which elicit robust
immunosuppressive functions within the CNS [4, 5]. Nonetheless, a number of studies have suggested that PACAP or VIP may elicit immune suppression through differing mechanisms on
microglial cells [6].
BV2 microglial cell cultures
Murine BV2 microglial cells were cultured in DMEM/F12 and
supplemented with 10% FBS, 100 U/ml penicillin, and 100 µg/ml
streptomycin and allowed to grow at 37°C in a humidified
atmosphere with 5% CO2. Cells were used between passage 25-35.
Real-time qPCR
Total RNA was reverse transcribed as per Bioline Tetro cDNA
synthesis kit protocol and transcripts were amplified using SYBR
green technology using the BioRad CFX96 Touch Real-Time PCR
Detection System. Primers were optimised for qPCR. S18
ribosomal protein subunit was used as housekeeping gene. 2-ΔΔCt
method was used to calculate fold changes [7].
Western blot analysis
Sample proteins (30µg) were diluted in Laemmli (BIO-RAD) and
β-mercaptoethanol (SIGMA-ALDRICH) mixture, heated at 70°C
for 10 min and then separated on a BIORAD 4-20% gradient
criterion mini gels (BIO-RAD).
Immunocytochemistry
Cells cultured on glass coverslips were fixed in 4% PFA,
permeabilised with 0.2% Triton X-100, blocked with 0.1% BSA in
PBS, then probed with the appropriated primary antibodies.
Griess reagent assay
Levels of nitric oxide (NO) in supernatants were quantified by the
Griess reaction. Cells (5×105) were treated with LPS in the
presence or not of PACAP and VIP for 12h. Media was then
replaced with freshly prepared one and incubated for a further
24hr. 100μl Griess reagent (Sigma-Aldrich, St. Louis, MO) was
added to an equal volume of conditioned media in a 96-well plate.
Absorbance was read using at an absorbance of 540nm using a
Tecan infinite M1000 Pro ELISA reader.
Morphological analyses
5×105cells were exposed to treatments for 12h as follows: Control,
LPS only, LPS+PACAP and LPS+VIP. Images were then captured
using the Nikon Eclipse TS2 inverted microscope and subjected to
morphological assortment and analyses. Specific criteria were
decided on and blinded individuals assigned randomised images to
analyse (see Table 1 for phenotypic criteria). Cells were grouped
in their classifications; a) small; b) medium; c) large and a)
rounded; b) bipolar/spindle; c) multipolar. Analyses of embossed
microscope images was performed using ImageJ 1.51 (NIH)
software.
Statistical analyses
Statistical analyses were performed using GraphPad Prism
software. Comparisons were computed using one-way ANOVA
followed by Tukey or Sidak’s post-hoc tests, as appropriate. P
values <0.05 were accepted as statistically significant.
Taken together, these results demonstrate that both PACAP and VIP possess robust anti-inflammatory activities in
experimentally activated BV2 microglial cells. However, from a morphological perspective, it appears that the two
peptides trigger distinct shifts of certain cell subpopulations towards specific phenotypes. Further studies are warranted
to unveil which biological functions are likely to be affected by these changes in cellular architecture.
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In this study, using lipopolysaccharide (LPS) to induce BV2
microglial cell polarisation, we aimed at testing whether and how
administration of either PACAP or VIP could differentially affect
microglial pro-inflammatory profile, polarisation state and
morphological appearance to elicit immunosuppressive effects.
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(1) PACAP & VIP reduce pro-
inflammatory cytokine mRNAs in LPS-
treated BV2 cells.
BV2 cells exposure to 1μg/ml LPS for
12hrs significantly increased the expression
levels of several pro-inflammatory
cytokines (circled in red). Treatment with
100nM PACAP or VIP reduced cytokines’
mRNA levels back to normal in most cases
(circled in blue). IL-10 levels did not seem
to be affected by LPS or peptide treatments.
***p<0.001 vs Control; #p<0.05 or ###p<0.001 vs LPS-treated
cells, as determined by one-way ANOVA followed by Tukey post-
hoc test (n= 4-6)
***p<0.001 vs Control; ##p<0.01 or 
###p<0.001 vs LPS-treated cells. One-
way ANOVA + Tukey post-hoc test (n=4)
**p<0.01 or ***p<0.001 vs Control; 
#p<0.05 or ###p<0.001 vs LPS-treated 
cells. One-way ANOVA + Tukey post-hoc 
test (n=4)
(2) PACAP & VIP
reduce Iba1 and iNOS
levels in LPS-treated
BV2 cells.
LPS-activated BV2 cells
exhibit increased levels of
M1 polarization markers,
both of which are
significantly reduced upon
treatment with PACAP or
VIP.
(3) PACAP & VIP decrease LPS-induced
Iba1-like immunoreactivity (IR) and
nitrites production in BV2 microglia.
Iba1-like IR was increased by treatment
with 1μg/ml LPS at 12h (*p<0.05).
Similarly, nitrite levels were also
augmented by LPS (***p<0.001). PACAP
or VIP rescued both Iba-like IR and nitrite
levels in treated cells (###p<0.001).
IHC-related statistics:*p<0.05 vs Control; ###p<0.001 vs LPS-
treated cells as determined by one-way ANOVA followed by Sidak
post-hoc test (n=6)
NO assay-related statistics: ***p<0.01 vs Control; ### p<0.001
vs LPS-treated cells as determined by one-way ANOVA followed
by Tukey post-hoc test (n=18)
Phenotype Descriptions Visual Example
Small cells/resting Round, oval-shaped 
cells with small soma 
and thin, long processes
Medium
cells/intermediate
In between the two 
phenotypes
Large cells/activated Multipolar or spindle-
shaped, flattened cells 
with hypertrophied 
soma and retracted, 
thick processes
TABLE 1 (4) VIP but not PACAP increase the number of intermediate/spindle
shaped cells in LPS-treated BV2 microglia.
Functional state statistics:*p<0.05 vs Control; #p<0.05, ##p<0.01 vs LPS-treated cells as determined by 2-way
repeated measures ANOVA followed by Tukey post-hoc test (n=40)
Subpopulation-related statistics: ***p<0.001 vs Control; #p<0.05 vs LPS-treated cells as determined by 2-way
RM ANOVA followed by Tukey post-hoc test (n=40)
